BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 225665)

  • 1. Drug therapy: metoprolol.
    Koch-Weser J
    N Engl J Med; 1979 Sep; 301(13):698-703. PubMed ID: 225665
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
    Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-invasive evaluation of some hemodynamic effects of metoprolol].
    Saettone G; Muzio L
    Boll Soc Ital Cardiol; 1981; 26(12):2119-21. PubMed ID: 7185378
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies with a new cardioselective beta-blocker, metoprolol.
    Werkö L; Aurell M; Johnsson G; Sannerstedt R; Svedmyr N
    Adv Clin Pharmacol; 1976; 11():19-25. PubMed ID: 1032569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Nov; 14(5):321-48. PubMed ID: 201441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
    Mattioli G; Ricci S; Bertoncelli P
    Minerva Cardioangiol; 1979; 27(7-8):463-72. PubMed ID: 44898
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute beta receptor blockade during the television transmission of the football world championship games 1978 in patients with a history of hypertension].
    Hüllemann KD; Busch O; Hüllemann B; Schroeter M; Schwarz A; Nosek O; Weber H; Wocheslander E; Zipplies C
    Med Welt; 1978 Dec; 29(51-52):2019-21. PubMed ID: 214665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
    Candau LA; Pereira LS; Scherr C
    Arq Bras Cardiol; 1981 Aug; 37(2):133-8. PubMed ID: 6753801
    [No Abstract]   [Full Text] [Related]  

  • 11. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.
    Benfield P; Clissold SP; Brogden RN
    Drugs; 1986 May; 31(5):376-429. PubMed ID: 2940080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoprolol--a new cardioselective beta adrenoceptor antagonist in experimental cardiac arrhythmias.
    Sivam SP; Seth SD
    Indian J Med Res; 1978 Jul; 68():176-82. PubMed ID: 700845
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-adrenergic antagonists in the treatment of patients with heart disease.
    Moses JW; Borer JS
    Dis Mon; 1981 Jun; 27(9):1-61. PubMed ID: 6114824
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of nitroglycerin and of a new beta-blocking agent (metroprlolo) on exercise tolerance in ischemic patients].
    Mosti GB; Tomei G; Giusti C; Galetta F; Rossi M; Santoro G
    Boll Soc Ital Cardiol; 1978; 23(3):589-96. PubMed ID: 111693
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
    Caimi G; Frazzetta F; Capobianco D; Catania A; Francavilla G; Sarno A
    Clin Ter; 1982 Nov; 103(4):383-8. PubMed ID: 7151384
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of calcium antagonists in therapy of coronary heart disease. Experimental report on the calcium antagonist fendiline, and the beta receptor blockader metoprolol].
    Ardjah H
    Med Welt; 1980 Sep; 31(37):1326-30. PubMed ID: 7432128
    [No Abstract]   [Full Text] [Related]  

  • 17. Nadolol: a new beta-adrenoceptor antagonist.
    Frishman WH
    N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].
    Demarchi PG; Mancini A; Brignole M; Astengo D; Bertulla A
    Minerva Cardioangiol; 1981 Dec; 29(12):719-28. PubMed ID: 7038536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic changes in patients with arterial hypertension after beta-receptor blockade with propranolol and metoprolol (author's transl)].
    Isbary J; Greding H; Nechwatal W; König E
    Z Kardiol; 1978 Dec; 67(12):857-62. PubMed ID: 735294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists.
    Frishman WH
    N Engl J Med; 1982 Jun; 306(24):1456-62. PubMed ID: 7043268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.